Nov 09, 2019 / 11:30PM GMT
Presentation
Nov 09, 2019 / 11:30PM GMT
=====================
Corporate Participants
=====================
* Michael Richman
NextCure - President and Chief Executive Officer
* Kevin Heller
NextCure - Chief Medical Officer
=====================
Conference Call Participants
=====================
* Jeffrey Hung
Morgan Stanley - Analyst
* Chad Messer
Needham & Company - Analyst
* Alec Stranahan
Bank of America Merrill Lynch - Analyst
=====================
Michael Richman - NextCure - President and Chief Executive Officer
Good evening. I'm Michal Richman, I'm President and CEO of NextCure, and I want to thank each and every person this evening to -- attending tonight's event. We greatly appreciate everyone's interest and support in the company, and in particular NC318.
It's nice to meet so many of you. We've talked on the phone through our testing the water meetings, and our roadshow over the last year. So it's great to meet some of the -- meet so many people
NextCure Inc Updated Clinical Data from NC318 Phase 1/2 Clinical Trial Presentation Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot